Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
de Zoeten
Edwin F
EF
Hancock
Wayne W
WW
D000818:Animals; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D024201:Bystander Effect; D002465:Cell Movement; D003092:Colitis / Q000139:chemically induced / Q000276:immunology / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D003106:Colon / Q000276:immunology / Q000378:metabolism; D004195:Disease Models, Animal; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D018928:Immunity, Mucosal; D016219:Immunotherapy, Adoptive; D007413:Intestinal Mucosa / Q000276:immunology / Q000378:metabolism; D008213:Lymphocyte Activation; D051379:Mice; D008822:Mice, Transgenic; D010081:Oxazolone; D010851:Picrates / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000378:metabolism / Q000637:transplantation*; D013997:Time Factors; D014302:Trinitrobenzenesulfonic Acid
D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; D010851:Picrates; D011948:Receptors, Antigen, T-Cell; D011993:Recombinant Fusion Proteins; D010081:Oxazolone; D014302:Trinitrobenzenesulfonic Acid; C005858:picric acid